Matinas BioPharma Holdings, Inc. (MTNB) — Institutional Holders, Q2 2026
25 institutional investment managers reported a MTNB position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $199.2K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
MTNB in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- RENAISSANCE TECHNOLOGIESAdded · +42,470 sh+$26.0K
- SUSQUEHANNA INTERNATIONAL GROUP, LLPAdded · +1,765 sh+$1.1K
- BlackRockAdded · +612 sh+$375.00
- NORTHWESTERN MUTUAL WEALTH MANAGEMENTNew · +20 sh+$12.00
- IFG AdvisoryNew · +10 sh+$6.00
Biggest sellers
- CITADEL ADVISORSTrimmed · -36,233 sh-$22.2K
- XTX Topco LtdSold out · -20,706 sh-$12.7K
- GEODE CAPITAL MANAGEMENTTrimmed · -16,035 sh-$9.8K
- VANGUARD FIDUCIARYTrimmed · -961 sh-$588.00
- UBS Group AGSold out · -184 sh-$113.00
MTNB 13F holders ranked 1–25 of 25
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | RENAISSANCE TECHNOLOGIES#1 · 71,040 sh | 71,040 | $43.5K | <0.01% | +148.7% |
| 2 | BlackRock#2 · 50,262 sh | 50,262 | $30.8K | 0.00% | +1.2% |
| 3 | GEODE CAPITAL MANAGEMENT#3 · 49,135 sh | 49,135 | $30.1K | 0.00% | -24.6% |
| 4 | VANGUARD CAPITAL MANAGEMENT#4 · 40,110 sh | 40,110 | $24.5K | 0.00% | 0.0% |
| 5 | Holos Integrated Wealth#5 · 32,480 sh | 32,480 | $20.2K | — | 0.0% |
| 6 | VANGUARD FIDUCIARY#6 · 17,316 sh | 17,316 | $10.6K | 0.00% | -5.3% |
| 7 | SUSQUEHANNA INTERNATIONAL GROUP, LLP#7 · 16,093 sh | 16,093 | $9.8K | 0.00% | +12.3% |
| 8 | CITADEL ADVISORS#8 · 15,465 sh | 15,465 | $9.5K | 0.00% | -70.1% |
| 9 | STATE STREET#9 · 15,322 sh | 15,322 | $9.4K | 0.00% | 0.0% |
| 10 | Sargent Investment Group#10 · 12,720 sh | 12,720 | $7.8K | <0.01% | 0.0% |
| 11 | Tower Research Capital (TRC)#11 · 2,853 sh | 2,853 | $1.7K | 0.00% | 0.0% |
| 12 | Vanguard Global Advisers#12 · 1,338 sh | 1,338 | $819.00 | 0.00% | 0.0% |
| 13 | MORGAN STANLEY#13 · 344 sh | 344 | $211.00 | 0.00% | 0.0% |
| 14 | Costello Asset Management#14 · 200 sh | 200 | $122.00 | 0.00% | 0.0% |
| 15 | WELLS FARGO & COMPANY#15 · 102 sh | 102 | $62.00 | 0.00% | 0.0% |
| 16 | JONES FINANCIAL COMPANIES LLLP#16 · 60 sh | 60 | $39.00 | 0.00% | 0.0% |
| 17 | EverSource Wealth Advisors#17 · 60 sh | 60 | $37.00 | 0.00% | -29.4% |
| 18 | OSAIC#18 · 52 sh | 52 | $31.00 | 0.00% | +4.0% |
| 19 | VISION FINANCIAL MARKETS#19 · 40 sh | 40 | $26.00 | — | 0.0% |
| 20 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT#20 · 20 sh | 20 | $12.00 | 0.00% | New |
| 21 | ROTHSCHILD INVESTMENT#21 · 14 sh | 14 | $9.00 | 0.00% | 0.0% |
| 22 | SBI Securities , Ltd.#22 · 12 sh | 12 | $7.00 | — | +9.1% |
| 23 | IFG Advisory#23 · 10 sh | 10 | $6.00 | 0.00% | New |
| 24 | Farther Finance Advisors#24 · 5 sh | 5 | $3.00 | — | 0.0% |
| 25 | Bogart Wealth#25 · 2 sh | 2 | $1.00 | 0.00% | 0.0% |
Funds that sold out of MTNB in Q2 2026 (5)
Held MTNB at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| XTX Topco Ltd20,706 sh | 20,706 | $10.4K |
| UBS Group AG184 sh | 184 | $92.00 |
| Steward Partners Investment Advisory61 sh | 61 | $31.00 |
| FMR7 sh | 7 | $4.00 |
| MAI Capital Management2 sh | 2 | $1.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.